News | January 14, 2026
ISVIR 2026 showcases cutting-edge interventional radiology in India
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
Backed by two CAP - accredited genomics labs in Delhi NCR and Mumbai, supporting oncology, reproductive health, neurology, transplant immunology, and rare diseases
CTx001 targets Geographic Atrophy (GA) secondary to Age-related Macular Degeneration
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding
New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern US
The agreement responds directly to President Trump’s demands that drugmakers cut costs for US patients
KRAS G12C-mutant advanced or metastatic nonsquamous non-small cell lung cancer
Appointment supports AstraZeneca’s $50 billion US investment and ambition to reach $80 billion in Total Revenue by 2030
Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering
Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections
Subscribe To Our Newsletter & Stay Updated
